Medtronic Cardiovascular
Clinical trials sponsored by Medtronic Cardiovascular, explained in plain language.
-
Heart valve study aims to confirm Real-World performance
Disease control OngoingThis study looks at how well the Medtronic Harmony Transcatheter Pulmonary Valve (TPV) works when used by doctors in everyday practice. It involves 150 people with certain heart defects who need a new pulmonary valve. The main goal is to see if the valve works properly and safely…
Phase: NA • Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated May 26, 2026 06:18 UTC
-
Chimney graft study aims to fix Hard-to-Treat aortic aneurysms
Disease control OngoingThis study tests a special technique called the chimney graft for treating abdominal aortic aneurysms that have a short neck, making standard surgery risky. About 150 adults will receive this procedure using Medtronic's Endurant stent grafts. The goal is to see if the technique i…
Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated May 26, 2026 06:17 UTC
-
New heart valve offers hope for High-Risk patients
Disease control OngoingThis study is testing a new heart valve device (Evolut PRO) in 52 Chinese patients with severe aortic stenosis who are too high-risk for open-heart surgery. The valve is placed through a tube in the artery, avoiding major surgery. Researchers are checking how many patients surviv…
Phase: NA • Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated May 26, 2026 06:17 UTC
-
Heart valve showdown: which TAVR device wins for small aortas?
Disease control OngoingThis study compares two types of replacement heart valves (self-expanding vs. balloon-expandable) in people with a small aortic valve opening and severe narrowing. About 1,100 participants will be followed to see which valve performs better in terms of survival, stroke, heart fai…
Phase: NA • Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated May 26, 2026 06:12 UTC
-
New hope for heart patients: less invasive valve replacement may help those with moderate disease
Disease control OngoingThis study tests whether a less invasive heart valve replacement (TAVR) is safe and effective for people with moderate aortic stenosis, a condition where the heart's aortic valve is narrowed but not yet severe. About 650 participants will receive the Evolut TAVR system and be fol…
Phase: NA • Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated May 26, 2026 06:10 UTC
-
New heart valve procedure offers hope for High-Risk patients
Disease control OngoingThis study tests a new device called the Intrepid Transcatheter Mitral Valve Replacement System for people with severe mitral regurgitation (a leaky heart valve) who are too high-risk for open-heart surgery. The goal is to see if the device is safe and works well. About 128 parti…
Phase: NA • Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
Heart valve showdown: TAVI vs. surgery for High-Risk patients
Disease control OngoingThis study compares two procedures—transcatheter aortic valve implantation (TAVI) and surgical valve replacement—in people with severe aortic stenosis who are at intermediate risk for surgery. About 1,700 participants were randomly assigned to one of the two treatments. The main …
Phase: NA • Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
New hope for heart patients: TAVR tested in bicuspid valve disease
Disease control OngoingThis study looks at a less invasive procedure called TAVR to replace the aortic valve in people with a bicuspid (two-leaflet) valve that is severely narrowed. The goal is to see if it is safe and works well in patients who are at low risk for open-heart surgery. About 150 partici…
Phase: NA • Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated May 19, 2026 12:00 UTC
-
New heart valve fix without open surgery shows promise for Low-Risk patients
Disease control OngoingThis study tests a less invasive procedure called TAVR against traditional open-heart surgery for people with severe aortic stenosis who are at low risk for surgery. About 2,200 participants will be followed for two years to see if TAVR is as safe and effective as surgery in prev…
Phase: NA • Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated May 18, 2026 12:12 UTC